低障碍键决定了抗结核药物贝达基林的目标结合亲和力和特异性
Joanna Słabońska1, Subrahmanyam Sappati1,2, Antoni Marciniak1,3
1Department of Physical Chemistry, Gdańsk University of Technology, Narutowicza St 11/12, Gdańsk 80-233, Poland.
ACS medicinal chemistry letters
|February 14, 2024
概括
短强键 (SSHBs) 对于贝达基林与真菌ATP合成酶结合至关重要. 修改这些键可以克服耐药性并扩大抗微生物药物的范围.
科学领域:
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
- 计算化学计算化学
背景情况:
- 短强键 (SSHBs) 在药物向相互作用中的作用尚未得到充分研究.
- 通过了解这些相互作用,可以推进合理的药物设计.
- 贝达基林 (Bq) 是一种抗结核药物,其向的是菌根性ATP合成酶.
研究的目的:
- 研究特定键在贝达基林对其菌根菌目标的亲和力和特异性的作用.
- 阐明SSHBs对药物标结合的自由能量的贡献.
- 探索克服贝达奎林耐药性的策略.
主要方法:
- 最初的分子动力学模拟被用来分析键相互作用.
- 使用计算建模来评估具有约束力的自由能源贡献.
- 贝达奎林类型的设计是为了测试抗性破坏策略而进行的.
主要成果:
- 贝达基林和菌根性ATP合成酶之间的关键键键被确定为SSHB,对结合能量有显著的贡献.
- 额外的酸性残留物 (位于32位的酸,D32位的酸),是菌根菌独有的,增强了SSHB的强度,并赋予了目标的特异性.
- 移除或突变D32减弱贝达基林亲和力,导致药物耐药性.
结论:
- 在贝达基林对抗菌根性ATP合成酶的有效性和特异性方面,SSHBs起着至关重要的作用.
- D32的存在对于高亲和度结合至关重要,并且是贝达基林抗菌活性的关键决定因素.
- 设计独立于D32的贝达基林类似物提供了一个有希望的策略来克服耐药性,并可能扩大该药物的抗菌谱.
相关概念视频
01:25Drug-Receptor Bonds
2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.8K
01:16Protein-Drug Binding: Mechanism and Kinetics
477
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
477
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
107
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
107
02:40Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
01:04Hydrogen Bonds
8.5K
A hydrogen bond is formed when a weakly positive hydrogen atom already bonded to one electronegative atom (for example, the oxygen in the water molecule) is attracted to another electronegative atom from another polar molecule, such as water (H2O), hydrogen fluoride (HF), or ammonia (NH3). The huge electronegativity difference between the H atom (2.1) and the atom to which it is bonded (4.0 for an F atom, 3.5 for an O atom, or 3.0 for an N atom), combined with the very small size of an H atom...
8.5K
01:30Drug Binding to Blood Components
149
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
149